MDB Capital Announces Record Date Of July 22, 2024 For IPO Of 4.3M Shares Of Common Stock For Invizyne Technologies At A Price Of $4/Share
$MDBH
Finance: Consumer Services
Finance
- Record date of July 22, 2024 set for allocation preferences
- Closing and trading expected on NASDAQ on or before August 15
Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected timeline for the proposed offering for Invizyne Technologies, Inc.
In February 2024, Invizyne – a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life and a subsidiary of MDB Capital Holdings – filed its IPO registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") for the sale of its common stock in a firm commitment public offering.